231 related articles for article (PubMed ID: 34660791)
1. The Impact of Metformin Use with Survival Outcomes in Urologic Cancers: A Systematic Review and Meta-Analysis.
Yao X; Liu H; Xu H
Biomed Res Int; 2021; 2021():5311828. PubMed ID: 34660791
[TBL] [Abstract][Full Text] [Related]
2. The impact of metformin use on survival in kidney cancer patients with diabetes: a meta-analysis.
Li Y; Hu L; Xia Q; Yuan Y; Mi Y
Int Urol Nephrol; 2017 Jun; 49(6):975-981. PubMed ID: 28271326
[TBL] [Abstract][Full Text] [Related]
3. Association of metformin intake with bladder cancer risk and oncologic outcomes in type 2 diabetes mellitus patients: A systematic review and meta-analysis.
Hu J; Chen JB; Cui Y; Zhu YW; Ren WB; Zhou X; Liu LF; Chen HQ; Zu XB
Medicine (Baltimore); 2018 Jul; 97(30):e11596. PubMed ID: 30045293
[TBL] [Abstract][Full Text] [Related]
4. Metformin Use and Kidney Cancer Survival Outcomes: A Systematic Review and Meta-Analysis.
Nayan M; Punjani N; Juurlink DN; Finelli A; Austin PC; Kulkarni GS; Uleryk E; Hamilton RJ
Am J Clin Oncol; 2019 Mar; 42(3):275-284. PubMed ID: 30663998
[TBL] [Abstract][Full Text] [Related]
5. The effect of metformin therapy on incidence and prognosis in prostate cancer: A systematic review and meta-analysis.
He K; Hu H; Ye S; Wang H; Cui R; Yi L
Sci Rep; 2019 Feb; 9(1):2218. PubMed ID: 30778081
[TBL] [Abstract][Full Text] [Related]
6. Metformin Improves Overall Survival of Colorectal Cancer Patients with Diabetes: A Meta-Analysis.
Meng F; Song L; Wang W
J Diabetes Res; 2017; 2017():5063239. PubMed ID: 28271076
[No Abstract] [Full Text] [Related]
7. Prognostic value of metformin in cancers: An updated meta-analysis based on 80 cohort studies.
Yang J; Yang H; Cao L; Yin Y; Shen Y; Zhu W
Medicine (Baltimore); 2022 Dec; 101(49):e31799. PubMed ID: 36626437
[TBL] [Abstract][Full Text] [Related]
8. The impact of metformin use on survival in prostate cancer: a systematic review and meta-analysis.
Xiao Y; Zheng L; Mei Z; Xu C; Liu C; Chu X; Hao B
Oncotarget; 2017 Nov; 8(59):100449-100458. PubMed ID: 29245991
[TBL] [Abstract][Full Text] [Related]
9. Metformin as an adjuvant treatment for cancer: a systematic review and meta-analysis.
Coyle C; Cafferty FH; Vale C; Langley RE
Ann Oncol; 2016 Dec; 27(12):2184-2195. PubMed ID: 27681864
[TBL] [Abstract][Full Text] [Related]
10. Effect of diabetes mellitus and metformin use on oncologic outcomes of patients treated with radical cystectomy for urothelial carcinoma.
Rieken M; Xylinas E; Kluth L; Crivelli JJ; Chrystal J; Faison T; Lotan Y; Karakiewicz PI; Sun M; Fajkovic H; Babjuk M; Bachmann A; Scherr DS; Shariat SF
Urol Oncol; 2014 Jan; 32(1):49.e7-14. PubMed ID: 24140245
[TBL] [Abstract][Full Text] [Related]
11. Urologic cancer in China.
Pang C; Guan Y; Li H; Chen W; Zhu G
Jpn J Clin Oncol; 2016 Jun; 46(6):497-501. PubMed ID: 27049022
[TBL] [Abstract][Full Text] [Related]
12. Prognostic role of pretreatment derived neutrophil to lymphocyte ratio in urological cancers: A systematic review and meta-analysis.
Su S; Liu L; Li C; Zhang J; Li S
Int J Surg; 2019 Dec; 72():146-153. PubMed ID: 31707011
[TBL] [Abstract][Full Text] [Related]
13. Association of diabetes mellitus and metformin use with oncological outcomes of patients with non-muscle-invasive bladder cancer.
Rieken M; Xylinas E; Kluth L; Crivelli JJ; Chrystal J; Faison T; Lotan Y; Karakiewicz PI; Fajkovic H; Babjuk M; Kautzky-Willer A; Bachmann A; Scherr DS; Shariat SF
BJU Int; 2013 Dec; 112(8):1105-12. PubMed ID: 24053906
[TBL] [Abstract][Full Text] [Related]
14. Effect of hypoglycemic agents on survival outcomes of lung cancer patients with diabetes mellitus: A meta-analysis.
Xin WX; Fang L; Fang QL; Zheng XW; Ding HY; Huang P
Medicine (Baltimore); 2018 Mar; 97(9):e0035. PubMed ID: 29489653
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the prognosis of primary and progressive muscle-invasive bladder cancer after radical cystectomy: A systematic review and meta-analysis.
Chen J; Zhang H; Sun G; Zhang X; Zhao J; Liu J; Shen P; Shi M; Zeng H
Int J Surg; 2018 Apr; 52():214-220. PubMed ID: 29496649
[TBL] [Abstract][Full Text] [Related]
16. Effect of Metformin Use on Survival and Recurrence Rate of Gastric Cancer After Gastrectomy in Diabetic Patients: A Systematic Review and Meta-analysis of Observational Studies.
Bahardoust M; Mousavi S; Moezi ZD; Yarali M; Tayebi A; Olamaeian F; Tizmaghz A
J Gastrointest Cancer; 2024 Mar; 55(1):65-76. PubMed ID: 37526857
[TBL] [Abstract][Full Text] [Related]
17. Pretreatment Neutrophil-Lymphocyte Ratio as a Predictor in Bladder Cancer and Metastatic or Unresectable Urothelial Carcinoma Patients: a Pooled Analysis of Comparative Studies.
Wu S; Zhao X; Wang Y; Zhong Z; Zhang L; Cao J; Ai K; Xu R
Cell Physiol Biochem; 2018; 46(4):1352-1364. PubMed ID: 29689562
[TBL] [Abstract][Full Text] [Related]
18. Differential Effect of Sex on Outcomes after Radical Surgery for Upper Tract and Bladder Urothelial Carcinoma: A Systematic Review and Meta-Analysis.
Mori K; Mostafaei H; Enikeev DV; Lysenko I; Quhal F; Kimura S; Karakiewicz PI; Egawa S; Shariat SF
J Urol; 2020 Jul; 204(1):58-62. PubMed ID: 31995432
[TBL] [Abstract][Full Text] [Related]
19. Metformin and prostate cancer mortality: a meta-analysis.
Stopsack KH; Ziehr DR; Rider JR; Giovannucci EL
Cancer Causes Control; 2016 Jan; 27(1):105-13. PubMed ID: 26537119
[TBL] [Abstract][Full Text] [Related]
20. Metformin Use is Associated with Improved Survival for Patients with Advanced Prostate Cancer on Androgen Deprivation Therapy.
Richards KA; Liou JI; Cryns VL; Downs TM; Abel EJ; Jarrard DF
J Urol; 2018 Dec; 200(6):1256-1263. PubMed ID: 29940252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
